Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation

BMC Cardiovascular Disorders

Volumn 14, Issue 1, 2014, Pages

  Sardu, Celestino ^a   Carreras, Giovanni ^b   Katsanos, Spyridon ^c   Kamperidis, Vasileios ^d   Pace, Maria Caterina ^e   Passavanti, Maria Beatrice ^e   Fava, Ilaria ^a   Paolisso, Pasquale ^a   Pieretti, Gorizio ^a   Nicoletti, Giovanni Francesco ^a   Santulli, Gaetano ^f   Paolisso, Giuseppe ^a   Marfella, Raffaele ^a,g  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b S MARIA HOSPITAL   (Italy)

^c KAT HOSPITAL   (Greece)

^d AHEPA UNIVERSITY HOSPITAL   (Greece)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f Department of Medicine   (United States)

^g Columbia University Medical Center New York ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CYCLIC AMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANGIOCARDIOGRAPHY; ARTERIOVENOUS FISTULA; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HEMATOMA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OXIDATIVE STRESS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY; CLINICAL TRIAL; COMPLICATION; RECURRENT DISEASE; VENTRICULAR PREMATURE COMPLEXES;

CATHETER ABLATION; HUMANS; METABOLIC SYNDROME X; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME; VENTRICULAR PREMATURE COMPLEXES;

EID: 84924910834     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-14-176     Document Type: Article

References (37)

1. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report Circulation 2002, 106:3143-3421.
2. Ford ES: The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the national health and nutrition examination survey II mortality study. Atherosclerosis 2004, 173:309-314.
3. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004, 110:1245-1250. 10.1161/01.CIR.0000140677.20606.0E
4. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes Federation Task Force on Epidemiology and Prevention: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009, 120:1640-1645. 10.1161/CIRCULATIONAHA.109.192644
5. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28:1769-1778. 10.2337/diacare.28.7.1769
6. Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S: Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol 2013, 62:697-703. 10.1016/j.jacc.2013.05.064
7. Soydinc S, Davutoglu V, Akcay M: Uncomplicated metabolic syndrome is associated with prolonged electrocardiographic QTc interval and QTc dispersion. Ann Noninvasive Electrocardiol 2006, 11:313-317. 10.1111/j.1542-474X.2006.00123.x
8. Lee KT, Tang PW, Tsai WC, Liu IH, Yen HW: Differential effects of central and peripheral fat tissues on the delayed rectifier K(+) outward currents in cardiac myocytes. Cardiology 2013, 125:118-124. 10.1159/000350360
9. Corbi GM, Carbone S, Ziccardi P, Giugliano G, Marfella R, Nappo F, Paolisso G, Esposito K, Giugliano D: FFAs and QT intervals in obese women with visceral adiposity: effects of sustained weight loss over 1 year. J Clin Endocrinol Metab 2002, 87:2080-2083. 10.1210/jcem.87.5.8516
10. Marfella R, De Angelis L, Nappo F, Manzella D, Siniscalchi M, Paolisso G, Giugliano D: Elevated plasma fatty acid concentrations prolong cardiac repolarization in healthy subjects. Am J Clin Nutr 2001, 73:27-30.
11. Provotorov VM, Glukhovskiĭ ML: Rhythm and conductivity disorders in patients at the initial stages of metabolic syndrome. Klin Med (Mosk) 2009, 87:26-28.
12. Provotorov VM, Glukhovskiĭ ML: Ventricular extrasystole in patients with metabolic syndrome. Klin Med (Mosk) 2010, 88:29-31.
13. Gaita F, Giustetto C, Di Donna P, Richiardi E, Libero L, Brusin MC, Molinari G, Trevi G: Long-term follow-up of right ventricular monomorphic extrasystoles. J Am Coll Cardiol 2001, 38:364-370. 10.1016/S0735-1097(01)01403-6
14. Lerman BB, Stein KM, Engelstein ED, Battleman DS, Lippman N, Bei D, Catanzaro D: Mechanism of repetitive monomorphic ventricular tachycardia. Circulation 1995, 92:421-429. 10.1161/01.CIR.92.3.421
15. Dong M, Ren J: What fans the fire: insights into mechanisms of leptin in metabolic syndrome- associated heart diseases. Curr Pharm Des 2014, 20:652-658. 10.2174/138161282004140213160930
16. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, European Heart Rhythm Association, Heart Rhythm Society, et al.: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology/American heart association task force and the European society of cardiology committee for practice Guidelines (Writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). J Am Coll Cardiol 2006, 48:e247-e346. 10.1016/j.jacc.2006.07.010
17. Wijnmaalen AP, Delgado V, Schalij MJ, Van Taxis CF VH, Holman ER, Bax JJ, Zeppenfeld K: Beneficial effects of catheter ablation on left ventricular and right ventricular function in patients with frequent premature ventricular contractions and preserved ejection fraction. Heart 2010, 96:1275-1280. 10.1136/hrt.2009.188722
18. Ischiropoulos H: Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998, 356:1-11. 10.1006/abbi.1998.0755
19. Alberti KG1, Zimmet P, Shaw J: Metabolic syndrome--a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 2006, 23:469-480. 10.1111/j.1464-5491.2006.01858.x
20. Duflou J, Virmani R, Rabin I, Burke A, Farb A, Smialek J: Sudden death as a result of heart disease in morbid obesity. Am Heart J 1995, 130:306-313. 10.1016/0002-8703(95)90445-X
21. Lalani AP, Kanna B, John J, Ferrick KJ, Huber MS, Shapiro LE: Abnormal signal-averaged electrocardiogram (SAECG) in obesity. Obes Res 2000, 8:20-28. 10.1038/oby.2000.4
22. Huang H, Amin V, Gurin M, Wan E, Thorp E: Diet-induced obesity causes long QT and reduces transcription of voltage-gated potassium channels. J Mol Cell Cardiol 2013, 59:151-158.
23. Schunkert H: Obesity and target organ damage: the heart. Int J Obes Relat Metab Disord 2002,26(Suppl 4):S15-S20.
24. Grekin RJ, Vollmer AP, Sider RS: Pressor effects of portal venous oleateinfusion. A proposed mechanism for obesity hypertension. Hypertension 1995, 26:193-198. 10.1161/01.HYP.26.1.193
25. Diaz-Melean CM, Somers VK, Rodriguez-Escudero JP, Singh P, Sochor O, Llano EM, Lopez-Jimenez F: Mechanisms of adverse cardiometabolic consequences of obesity. Curr Atheroscler Rep 2013, 15:364.
26. Endoh Y, Endoh I, Geczy C, Nakagomi A, Kusama Y: Inflammation and atrial fibrillation. J Arrhythmia 2011, 27:106-115. 10.1016/S1880-4276(11)80017-7
27. Drolet B, Simard C, Gailis L, Daleau P: Ischemic, genetic and pharmacological origins of cardiac arrhythmias: the contribution of the Quebec heart institute. Can J Cardiol 2007,23(Suppl B):15B-22B.
28. Jeong EM, Liu M, Sturdy M, Gao G, Varghese ST, Sovari AA, Dudley SC Jr: Metabolic stress, reactive oxygen species, and arrhythmia. J Mol Cell Cardiol 2012, 52:454-463. 10.1016/j.yjmcc.2011.09.018
29. Bharati S, Lev M: Cardiac conduction system involvement in sudden death of obese young people. Am Heart J 1995, 129:273-281. 10.1016/0002-8703(95)90008-X
30. Tandri H, Saranathan M, Rodriguez ER, Martinez C, Bomma C, Nasir K, Rosen B, Lima JA, Calkins H, Bluemke DA: Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005, 45:98-103. 10.1016/j.jacc.2004.09.053
31. Nazarian S, Bluemke DA, Halperin HR: Applications of cardiac magnetic resonance in electrophysiology. Circ Arrhythm Electrophysiol 2009, 2:63-71. 10.1161/CIRCEP.108.811562
32. Globits S, Kreiner G, Frank H, Heinz G, Klaar U, Frey B, Gössinger H: Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia. Circulation 1997, 96:2633-2640. 10.1161/01.CIR.96.8.2633
33. Ling Z, Liu Z, Su L, Zipunnikov V, Wu J, Du H, Woo K, Chen S, Zhong B, Lan X, Fan J, Xu Y, Chen W, Yin Y, Nazarian S, Zrenner B: Radiofrequency ablation vs. antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: a prospective randomized study. Circ Arrhythm Electrophysiol 2014, 7:237-243. 10.1161/CIRCEP.113.000805
34. Sporton S, Earley M, Nathan A, Schilling R: Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study. J Cardiovasc Electrophysiol 2004, 15:310-315. 10.1111/j.1540-8167.2004.03356.x
35. Shpun S, Gepstein L, Hayam G, Ben-Haim S: Guidance of radiofrequency endocardial ablation with real-time three-dimensional magnetic navigation system. Circulation 1997, 96:2016-2021. 10.1161/01.CIR.96.6.2016
36. Smeets J, Ben-Haim S, Rodriguez L, Timmermans C, Wellens H: New method for nonfluoroscopic endocardial mapping in humans. Accuracy assessment and first clinical results. Circulation 1998, 97:2426-2432. 10.1161/01.CIR.97.24.2426
37. Mohanty S, Mohanty P, Di Biase L, Bai R, Pump A, Santangeli P, Burkhardt D, Gallinghouse JG, Horton R, Sanchez JE, Bailey S, Zagrodzky J, Natale A: Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J Am Coll Cardiol 2012, 59:1295-1301. 10.1016/j.jacc.2011.11.051